← Open Payments lookup

KERRY TAVEIRA: Open Payments

NPI 1447222856 · SWANSEA, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$910 in 64 payments from 13 companies in 2025. Trend: 2023 $999 · 2024 $791 · 2025 $910

Food & beverage: $910
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.27$167
Alkermes, Inc.9$154
Neurocrine BioSciences, Inc.5$103
Axsome Therapeutics, Inc.5$102
ABBVIE INC.4$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$67
Janssen Pharmaceuticals, Inc3$65
Vanda Pharmaceuticals Inc.2$53
Supernus Pharmaceuticals, Inc.2$46
Collegium Pharmaceutical, Inc.1$21

Products named: ARISTADA, REXULTI, INGREZZA, Auvelity, VRAYLAR, CAPLYTA, FANAPT, Qelbree.

Industry payments across MA — which companies pay providers there.